Lady Mireille founded and grew HUYABIO International to be the leader in accelerating the advancement of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective, and lower-risk drug development in global markets. Through this model Hiyasta, an immuno-oncology drug that treats patients with cancer has been successfully launched in Japan. Lady Mireille was appointed to the Board of Quintiles, now IQVIA, a Fortune 500 company. Currently, she serves on the Pasteur Institute advisory board.
Mireille and Dennis realised the need for a European private equity fund specialising in global health opportunities and financially co-founded GHO Capital. They were the cornerstone investor for the inception of GHO. Among the many honors she has received, the French Government awarded Mireille its highest national award, the Knight of the Legion of Honor in recognition of her contributions to neuroscience and entrepreneurship. Lady Mireille was bestowed an Honorary Degree by the University of Exeter. She has also twice been named by the UK Sunday Times as one of the Top Female Entrepreneurs.